Surotomycin versus vancomycin in adults with Clostridium difficile infection: primary clinical outcomes from the second pivotal, randomized, double-blind, Phase 3 trial.
about
Surotomycin versus vancomycin in adults with Clostridium difficile infection: primary clinical outcomes from the second pivotal, randomized, double-blind, Phase 3 trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Surotomycin versus vancomycin ...... , double-blind, Phase 3 trial.
@en
Surotomycin versus vancomycin ...... , double-blind, Phase 3 trial.
@nl
type
label
Surotomycin versus vancomycin ...... , double-blind, Phase 3 trial.
@en
Surotomycin versus vancomycin ...... , double-blind, Phase 3 trial.
@nl
prefLabel
Surotomycin versus vancomycin ...... , double-blind, Phase 3 trial.
@en
Surotomycin versus vancomycin ...... , double-blind, Phase 3 trial.
@nl
P2093
P2860
P356
P1476
Surotomycin versus vancomycin ...... , double-blind, Phase 3 trial.
@en
P2093
A Adedoyin
K B Larson
U Stoutenburgh
P2860
P304
P356
10.1093/JAC/DKX299
P407
P577
2017-09-06T00:00:00Z